Screening methods, devices and kits for detecting mucous membrane carbohydrates and related conditions

Abstract

The present disclosure relates to screening test methods, devices, and kits for mucosal carbohydrates and related conditions, including cancerous and pre-cancerous conditions. In particular, the method uses a galactose oxidase reagent and a Schiff reagent for testing abnormal carbohydrates in mucus or bodily fluids. The screening test methods, devices, and kits provide improved accuracy and minimize processing procedures. The present disclosure also relates to the use of the device or kit in a health care facility for the preliminary evaluation of cancerous and pre-cancerous conditions.

Description

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS [0002] This application claims priority to and the benefit of US Provisional Application No. 62 / 893,477, filed August 29, 2019, and US Non-Provisional Patent Application No. 16 / 936,998, filed July 23, 2020, the entire contents of which are hereby incorporated by reference in their entirety Incorporated herein. technical field [0003] The present disclosure generally relates to screening test methods, devices and kits for the detection of mucosal carbohydrates and related disorders, including but not limited to cancerous and precancerous disorders. Specifically, the method uses the enzymes galactose oxidase and Schiffs Reagent to test for abnormal carbohydrates in mucus or body fluids. The present disclosure also relates to the use of the device or kit in a healthcare facility for the initial assessment of abnormal carbohydrates and related disorders. Background technique [0004] Early detection and prevention remain the b...

AI Technical Summary

Problems solved by technology

[0008] However, the test kit includes multiple liquid components, and the test method requires multiple steps, which will produce false negatives through sampling or procedural errors

Images